Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia
Clinical trial NCT06802718 · RECRUITING
Trial details
- NCT number
- NCT06802718
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2026-12-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.